Annual EBITDA:
-$92.74M+$50.42M(+35.22%)Summary
- As of today, ANAB annual EBITDA is -$92.74 million, with the most recent change of +$50.42 million (+35.22%) on December 31, 2024.
- During the last 3 years, ANAB annual EBITDA has fallen by -$38.49 million (-70.94%).
- ANAB annual EBITDA is now -1911.05% below its all-time high of $5.12 million, reached on December 31, 2014.
Performance
ANAB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$25.57M+$1.36M(+5.06%)Summary
- As of today, ANAB quarterly EBITDA is -$25.57 million, with the most recent change of +$1.36 million (+5.06%) on June 30, 2025.
- Over the past year, ANAB quarterly EBITDA has increased by +$14.16 million (+35.64%).
- ANAB quarterly EBITDA is now -176.35% below its all-time high of $33.49 million, reached on December 31, 2020.
Performance
ANAB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$83.73M+$14.16M(+14.46%)Summary
- As of today, ANAB TTM EBITDA is -$83.73 million, with the most recent change of +$14.16 million (+14.46%) on June 30, 2025.
- Over the past year, ANAB TTM EBITDA has increased by +$68.92 million (+45.15%).
- ANAB TTM EBITDA is now -977.97% below its all-time high of $9.54 million, reached on September 30, 2021.
Performance
ANAB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ANAB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +35.2% | +35.6% | +45.1% |
| 3Y3 Years | -70.9% | +6.1% | +12.1% |
| 5Y5 Years | +2.4% | -13.7% | -6.1% |
ANAB EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -70.9% | +35.2% | -181.9% | +41.6% | at high | +45.9% |
| 5Y | 5-Year | -406.4% | +35.2% | -176.3% | +41.6% | -978.0% | +45.9% |
| All-Time | All-Time | -1911.0% | +35.2% | -176.3% | +41.6% | -978.0% | +45.9% |
ANAB EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$25.57M(+5.1%) | -$83.73M(+14.5%) |
| Mar 2025 | - | -$26.93M(-197.0%) | -$97.89M(+13.0%) |
| Dec 2024 | -$92.74M(+35.2%) | -$9.07M(+59.1%) | -$112.55M(+18.2%) |
| Sep 2024 | - | -$22.16M(+44.2%) | -$137.68M(+9.8%) |
| Jun 2024 | - | -$39.73M(+4.5%) | -$152.65M(-0.1%) |
| Mar 2024 | - | -$41.60M(-21.7%) | -$152.48M(+1.4%) |
| Dec 2023 | -$143.16M(-36.0%) | -$34.19M(+7.9%) | -$154.70M(-6.0%) |
| Sep 2023 | - | -$37.14M(+6.1%) | -$145.87M(-5.9%) |
| Jun 2023 | - | -$39.56M(+9.7%) | -$137.78M(-9.8%) |
| Mar 2023 | - | -$43.81M(-72.7%) | -$125.45M(-11.2%) |
| Dec 2022 | -$105.26M(-94.0%) | -$25.37M(+12.7%) | -$112.82M(+4.6%) |
| Sep 2022 | - | -$29.05M(-6.7%) | -$118.22M(-24.1%) |
| Jun 2022 | - | -$27.23M(+12.7%) | -$95.27M(-40.8%) |
| Mar 2022 | - | -$31.18M(-1.3%) | -$67.66M(-23.6%) |
| Dec 2021 | -$54.26M(-196.3%) | -$30.77M(-405.0%) | -$54.72M(-673.8%) |
| Sep 2021 | - | -$6.09M(-1712.2%) | $9.54M(+211.3%) |
| Jun 2021 | - | $378.00K(+102.1%) | -$8.57M(+72.8%) |
| Mar 2021 | - | -$18.24M(-154.5%) | -$31.44M(-34.8%) |
| Dec 2020 | -$18.31M(+80.7%) | $33.49M(+238.4%) | -$23.32M(+70.5%) |
| Sep 2020 | - | -$24.20M(-7.6%) | -$78.93M(+10.7%) |
| Jun 2020 | - | -$22.50M(-122.5%) | -$88.34M(+4.5%) |
| Mar 2020 | - | -$10.11M(+54.3%) | -$92.47M(+13.6%) |
| Dec 2019 | -$95.04M | -$22.12M(+34.2%) | -$107.02M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$33.61M(-26.2%) | -$104.46M(-19.2%) |
| Jun 2019 | - | -$26.63M(-8.0%) | -$87.64M(-16.3%) |
| Mar 2019 | - | -$24.66M(-26.1%) | -$75.36M(-13.5%) |
| Dec 2018 | -$59.88M(-113.0%) | -$19.56M(-16.4%) | -$66.41M(-23.1%) |
| Sep 2018 | - | -$16.80M(-17.0%) | -$53.95M(-16.8%) |
| Jun 2018 | - | -$14.35M(+8.6%) | -$46.20M(-34.5%) |
| Mar 2018 | - | -$15.70M(-121.0%) | -$34.35M(-20.1%) |
| Dec 2017 | -$28.11M(-687.9%) | -$7.10M(+21.4%) | -$28.60M(-16.2%) |
| Sep 2017 | - | -$9.04M(-261.1%) | -$24.61M(-48.4%) |
| Jun 2017 | - | -$2.50M(+74.8%) | -$16.59M(-42.3%) |
| Mar 2017 | - | -$9.95M(-219.3%) | -$11.66M(-317.6%) |
| Dec 2016 | -$3.57M(+21.3%) | -$3.12M(-206.4%) | -$2.79M(+13.0%) |
| Sep 2016 | - | -$1.02M(-142.0%) | -$3.21M(-13.9%) |
| Jun 2016 | - | $2.42M(+323.9%) | -$2.82M(+38.2%) |
| Mar 2016 | - | -$1.08M(+69.4%) | -$4.55M(-49.4%) |
| Dec 2015 | -$4.53M(-188.5%) | -$3.53M(-465.3%) | -$3.05M(-380.7%) |
| Sep 2015 | - | -$625.00K(-191.2%) | $1.09M(-79.4%) |
| Jun 2015 | - | $685.00K(+61.2%) | $5.26M(-13.1%) |
| Mar 2015 | - | $425.00K(-29.3%) | $6.06M(+17.0%) |
| Dec 2014 | $5.12M(+225.5%) | $601.00K(-83.1%) | $5.18M(+13.1%) |
| Sep 2014 | - | $3.55M(+139.9%) | $4.58M(+345.7%) |
| Jun 2014 | - | $1.48M(+426.7%) | $1.03M(+326.7%) |
| Mar 2014 | - | -$453.00K | -$453.00K |
| Dec 2013 | -$4.08M | - | - |
FAQ
- What is AnaptysBio, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for AnaptysBio, Inc.?
- What is AnaptysBio, Inc. annual EBITDA year-on-year change?
- What is AnaptysBio, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for AnaptysBio, Inc.?
- What is AnaptysBio, Inc. quarterly EBITDA year-on-year change?
- What is AnaptysBio, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for AnaptysBio, Inc.?
- What is AnaptysBio, Inc. TTM EBITDA year-on-year change?
What is AnaptysBio, Inc. annual EBITDA?
The current annual EBITDA of ANAB is -$92.74M
What is the all-time high annual EBITDA for AnaptysBio, Inc.?
AnaptysBio, Inc. all-time high annual EBITDA is $5.12M
What is AnaptysBio, Inc. annual EBITDA year-on-year change?
Over the past year, ANAB annual EBITDA has changed by +$50.42M (+35.22%)
What is AnaptysBio, Inc. quarterly EBITDA?
The current quarterly EBITDA of ANAB is -$25.57M
What is the all-time high quarterly EBITDA for AnaptysBio, Inc.?
AnaptysBio, Inc. all-time high quarterly EBITDA is $33.49M
What is AnaptysBio, Inc. quarterly EBITDA year-on-year change?
Over the past year, ANAB quarterly EBITDA has changed by +$14.16M (+35.64%)
What is AnaptysBio, Inc. TTM EBITDA?
The current TTM EBITDA of ANAB is -$83.73M
What is the all-time high TTM EBITDA for AnaptysBio, Inc.?
AnaptysBio, Inc. all-time high TTM EBITDA is $9.54M
What is AnaptysBio, Inc. TTM EBITDA year-on-year change?
Over the past year, ANAB TTM EBITDA has changed by +$68.92M (+45.15%)